Skip to content

TheraSeed® TS200CSA

by Bard Brachytherapy, Inc

TheraSeed® TS200CSA is a Class II device made by Bard Brachytherapy, Inc, cleared under FDA 510(k) K060636 on 19 Apr 2006 and listed in FDA GUDID since 5 Oct 2015 (UDI-DI 00801741091353), active as of 23 Oct 2026.

Active United States. Also listed in GUDID (US).

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 23 Oct 2026

Documents

510(k) K060636

FDA submission, from GUDID

Trust

Unverified

Source GUDID, synced 23 Oct 2026.

Regulatory status

as of registry sync 23 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number00801741091353 UDI-DI Date5 Oct 2015ListedStatusListed GUDID: in commercial distribution
United StatesFDA 510(k)SESE from GUDID Substantially Equivalent · Traditional NumberK060636 Date19 Apr 2006DecidedStatusActive

Official records

Across registries

2 registries list this device

  • FDA 510(k) K060636 decided 19 Apr 2006 Active
  • FDA GUDID UDI-DI 00801741091353 listed 5 Oct 2015 Listed

Timeline

2 dated events

  1. Cleared FDA 510(k) K060636
  2. Listed FDA GUDID 00801741091353

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

GUDID

Trade name
TheraSeed®
Generic name
Manual brachytherapy source, permanent implant
Model / Ref / Catalog
TS200CSA
Primary DI / UDI-DI
00801741091353
510(k) Number
FDA product code
KXK
GMDN term
Manual brachytherapy source, permanent implant
Device class
Class II
Regulation number
892.5730
GUDID distribution status
In Commercial Distribution

Similar devices

Other devices filed under FDA product code KXK (Source, brachytherapy, radionuclide).

Other devices from Bard Brachytherapy, Inc

See all devices from Bard Brachytherapy, Inc →

Properties

  • Supplied sterile
  • Single use
  • Implantable
  • Prescription use
  • Convenience kit
  • Serial number
  • Expiration date
Other properties (8, all answered No)